Company
e-therapeutics plc
Headquarters: Long Hanborough, United Kingdom
Employees: 33
CEO: Mr. Ahmad Ali Mortazavi
Market Cap
£65.7 Million
GBP as of Jan. 1, 2024
US$83.6 Million
e-therapeutics plc Categories
United Kingdom Healthcare BiotechnologyUnited Kingdom Healthcare United Kingdom Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
e-Therapeutics plc operates as a drug discovery company in the United Kingdom. The company's Network-Driven Drug Discovery platform perform in silico phenotypic screens to generate sets of small molecules that are enriched in active compounds ensuring high in vitro hit rates in complex phenotypic screens; and Genome-Associated Interaction Networks platform to analyze genome-wide association study data, which identifies disease variants at the genome level to identify potential intervention strategies, therapies, and diagnostics, as well as developing RNAi platform to modulate any gene to harness novel targets identified computationally. It also develops search engine technology. The company was founded in 2001 and is based in Long Hanborough, the United Kingdom.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
e-therapeutics plc has the following listings and related stock indices.
Stock: LSE: ETX wb_incandescent
Stock: OTC: ETXPF wb_incandescent